tirzepatide who makes FDA approves new weight loss drug with remarkable track record Ozempic maker Novo Nordisk sues

Also read: Ozempics Effects on Your Brain: A Personal Exploration

Tyna: Thanks for having me

Statins remain the most effective medication for lowering LDL cholesterol and reducing cardiovascular risk

One recent analysis of six years of medical records from the Department of Veterans Affairs, which reviewed the records of 2 million patients with diabetes, found that those taking a GLP-1 agonist medication had a reduced risk of developing dementia, including Alzheimers, as well as psychiatric and substance use disorders, though it also found an increased risk of gastrointestinal disorders, kidney stones, and pancreatitis

10.1038/s41467-024-54080-w 105 VarnumA

Consequently, it has become difficult for manufacturing companies to oppose to the withdrawal of these combinations by the FDA, that, finally, in 2004 banned Ephedra and ephedrine products due to the unpredictable risk of adverse events